EUPRAXIA PHARMACEUTICALS INC. Deferred Tax Assets, Operating Loss Carryforwards
EUPRAXIA PHARMACEUTICALS INC. (EPRX) had Deferred Tax Assets, Operating Loss Carryforwards of $30.56 million as of 2025-12-31, per its 40-F filed 2026-03-13.
Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-13
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $30.56M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $22.22M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $18.35M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $12.78M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $30.56M 40-F · filed 2026-03-13 |
| 2024-12-31 | $22.22M 40-F · filed 2026-03-13 |
| 2023-12-31 | $18.35M 40-F · filed 2025-03-20 |
| 2022-12-31 | $12.78M 40-F · filed 2024-04-01 |